Position in RGNX
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$8,764,398
+$297,407 QoQ
Shares Held
731,586
-27.6% QoQ
Ownership
1.11%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#14
of 163 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 87%
Shared 7%
None 7%
Common Shares in RGNX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026DIMENSIONAL FUND ADVISORS LP holds $6,105,781,867 across 230 Biotechnology names. RGNX ranks #87 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,168,956 | $580,655,511 | |
| 2 | JAZZ |
Jazz Pharmaceuticals plc
|
1,713,592 | $412,924,262 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
559,687 | $348,987,230 | |
| 4 | INCY |
Incyte Corp
|
2,280,803 | $258,551,825 | |
| 5 | EXEL |
Exelixis, Inc.
|
4,426,620 | $240,852,392 | |
| 6 | BMRN |
Biomarin Pharmaceutical Inc
|
4,075,714 | $233,212,353 | |
| 7 | ROIV |
Roivant Sciences Ltd.
|
5,230,417 | $185,104,455 | |
| 8 | KRYS |
Krystal Biotech, Inc.
|
476,038 | $176,929,041 |
All Filings in RGNX
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,764,398 | 731,586 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $8,466,991 | 1,010,381 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $13,015,453 | 903,851 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $10,663,509 | 1,105,027 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $9,217,882 | 1,122,763 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $8,206,239 | 1,147,726 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $9,055,089 | 1,171,422 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $12,065,469 | 1,150,188 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $12,957,198 | 1,107,453 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $25,222,326 | 1,197,073 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $22,023,876 | 1,226,957 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $19,629,734 | 1,192,572 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $27,746,397 | 1,388,014 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $29,048,235 | 1,536,131 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $30,835,453 | 1,359,588 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $33,145,888 | 1,254,101 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $26,614,099 | 1,077,494 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $25,859,722 | 779,142 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $24,507,734 | 749,472 | Shares | Defined | 2022-02-09 | |
| 2021-09-30 | $27,949,824 | 666,742 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $36,980,654 | 951,883 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $28,218,077 | 827,267 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $31,363,899 | 691,444 | Shares | Defined | 2021-03-08 | |
| 2020-09-30 | $18,857,969 | 685,246 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $25,850,129 | 701,877 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $22,238,551 | 686,799 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||